
    
      PLWH taking or initiating/re-initiating TAF will be recruited for a 16-week study. Upon
      entering the study, participants will be trained on the use the digital pill to objectively
      quantify adherence. Study participants already taking TAF will return every 4 weeks for a
      study visit where blood for drug concentrations will be obtained. Participants
      initiating/re-initiating TAF will return weekly for the first 4 weeks, at weeks 6 and 8, and
      every 4 weeks thereafter for a study visit where drug concentrations will be obtained.
    
  